Results 51 to 60 of about 2,920 (152)

NSUN2 promotes leukemogenesis by ferritin heavy chain 1-mediated anti-ferroptosis and enhancing global protein synthesis in an m5C-dependent manner in B-acute lymphoblastic leukemia

open access: yesClinical Epigenetics
Background NOP2/Sun RNA methyltransferase family member 2 (NSUN2) catalyzes 5-methylcytosine (m5C) modifications in tRNA, rRNA, and mRNA, playing critical roles in various malignancies.
Yigang Yuan   +13 more
doaj   +1 more source

Methylation-dependent and -independent functions of NSUN2.

open access: yes, 2019
(A) Schematic representation of NSUN2-methylated tRNA sites in the anticodon loop (C34) and the VL (C46, C47). (B, C) Number of m5C per tRNA in all tRNAs (B) or tRNA leucine (C) quantified by mass spectrometry in NSUN2−/ cells reexpressing NSUN2, the ...
Sandra Blanco (34725)   +14 more
core   +1 more source

DataSheet_1_Distinct Roles of m5C RNA Methyltransferase NSUN2 in Major Gynecologic Cancers.pdf

open access: yes, 2022
RNA methylation has recently emerged as an important category of epigenetic modifications, which plays diverse physiopathological roles in various cancers.
Yasen Maimaitiyiming (1637338)   +11 more
core   +1 more source

NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma

open access: yesFrontiers in Oncology, 2022
Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in the head and neck with a complex etiology, such as environmental factors, genetic factors, and Epstein–Barr virus infection.
Xinya Tong   +10 more
doaj   +1 more source

FTSJ3‐Mediated 2′‐O‐Methylation of HSPA5 mRNA Stabilizes BOP1 via SUMOylation to Drive DRP1‐Dependent Mitochondrial Fission and Fatty Acid Oxidation in Lung Squamous Cell Carcinoma

open access: yesAdvanced Science, EarlyView.
The RNA methyltransferase FTSJ3 drives lung squamous cell carcinoma progression by catalyzing 2′‐O‐methylation of HSPA5 mRNA, which stabilizes BOP1 through SUMOylation and activates DRP1/SREBP1‐mediated mitochondrial fission and fatty acid oxidation. Targeting this axis with liposomal siRNA potently suppresses tumor growth and metastasis ABSTRACT Lung ...
Qin Hu   +4 more
wiley   +1 more source

The subcellular localization and functions of NSUN2 in LIHC, LUAD and HNSC.

open access: yes, 2023
(A) The subcellular localization of NSUN2 in HepG2, A549 and 5-8F cells. (B) Detection of the overexpression efficiency of NSUN2 in cell lines. (C) The effect of NSUN2 overexpression on cell proliferation was tested by CCK-8 assay in HepG2, A549 and 5-8F
Wei Xiong (58411)   +11 more
core   +1 more source

NSUN3‐Associated m5C Modification of tRF5‐GlyTCC Suppresses Colorectal Cancer Progression via RPL23‐Linked Nucleolar Stress and p53‐Associated Autophagy and Enhances 5‐FU Sensitivity

open access: yesAdvanced Science, EarlyView.
This study identifies that NSUN3‐mediated m5C modification stabilizes tRF5‐GlyTCC, linking ribosomal homeostasis, nucleolar stress responses, and p53 signaling changes. This regulatory axis suppresses colorectal cancer and enhances chemotherapy response to 5‐FU, positioning tRF5‐GlyTCC as a potential therapeutic target for improving drug sensitivity in
Xinhui Lv   +8 more
wiley   +1 more source

The relationships between the expression levels of NSUN2 and TILs or immune-related gene.

open access: yes, 2023
(A) Expression analysis between NSUN2 and TILs including B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages and dendritic cells. (B) The correlation between the expression levels of NSUN2 and neutrophils.
Wei Xiong (58411)   +11 more
core   +1 more source

NSUN2 relies on ALYREF to regulate Nrf2-mediated oxidative stress and alleviate Dox-induced liver injury

open access: yesBiology Direct
Background Doxorubicin (Dox) is associated with various liver injuries, limiting its clinical utility. This study investigates whether NSUN2 participates in Dox-induced liver injury and the associated molecular mechanism.
Yingying Huang   +8 more
doaj   +1 more source

Epigenomic Cascades Across Organs in Metabolic Dysfunction–Associated Steatotic Liver Disease: New Therapeutic Horizons

open access: yesObesity Reviews, EarlyView.
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disorder worldwide, affecting approximately one‐third of the population and increasing the risk of severe hepatic and cardiovascular complications.
Shurui Yang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy